Consun Pharmaceutical Group Limited
CPHGF
$1.08
$0.0747.34%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.48% | 35.46% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.48% | 35.46% | |||
| Cost of Revenue | -0.48% | 27.33% | |||
| Gross Profit | -0.48% | 38.21% | |||
| SG&A Expenses | -0.48% | 40.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 0.48% | -56.84% | |||
| Total Operating Expenses | -0.48% | 35.49% | |||
| Operating Income | -0.48% | 35.38% | |||
| Income Before Tax | -0.48% | 36.63% | |||
| Income Tax Expenses | -0.48% | 113.77% | |||
| Earnings from Continuing Operations | -0.48% | 30.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.48% | -384.36% | |||
| Net Income | -0.48% | 29.22% | |||
| EBIT | -0.48% | 35.38% | |||
| EBITDA | -0.48% | 28.97% | |||
| EPS Basic | -0.47% | 23.26% | |||
| Normalized Basic EPS | -0.67% | 28.76% | |||
| EPS Diluted | -0.48% | 22.06% | |||
| Normalized Diluted EPS | -0.34% | 28.26% | |||
| Average Basic Shares Outstanding | 0.00% | 4.86% | |||
| Average Diluted Shares Outstanding | 0.00% | 5.23% | |||
| Dividend Per Share | -0.50% | 3.11% | |||
| Payout Ratio | 0.00% | -0.60% | |||